2023-03-10 10:16:05 ET
- Eagle Pharmaceuticals ( NASDAQ: EGRX ) is scheduled to announce Q4 earnings results on Monday, March 13th, before market open.
- The consensus EPS Estimate is $0.83 (-2.4% Y/Y) and the consensus Revenue Estimate is $64.26M (+51.8% Y/Y).
- Over the last 2 years, EGRX has beaten EPS estimates 38% of the time and has beaten revenue estimates 25% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 1 downward.
For further details see:
Eagle Pharmaceuticals Q4 2022 Earnings Preview